Olympus Corporation Consolidated Financial Results for the 3rd Quarter for Fiscal Year 2025

Yasuo Takeuchi
Director, Representative Executive Officer, Executive Chairperson and ESG Officer
Tatsuya Izumi
Executive Officer and Chief Financial Officer
Frank Drewalowski
Executive Officer and Endoscopic Solutions Division Head
Gabriela Kaynor
Executive Officer and Chief Strategy Officer
Seiji Kuramoto
Executive Officer and Therapeutic Solutions Division Head
Boris Shkolnik
Executive Officer and Chief Quality Officer

PLAY LIST

from the beginning

Consolidated Financial Results for the 3rd Quarter for Fiscal Year 2025

3Q (9 months) Consolidated Financial Results

Changes to More Efficient and Patient -and Customer-centric Structure

GIS: Full GI Ecosystem Vision Integrated within One Division

Launching OLYSENSE: First CAD/AI Products in Q1 FY2026

Elevate: Initiatives to Shorten the Lead Time to Get Clearance/approval and Launch Products

Disclosure Plan for Re-alignment of Divisional Structure

3Q of Fiscal Year 2025 Consolidated Financial Results

3Q of Fiscal Year 2025 Endoscopic Solutions Division (ESD)

3Q of Fiscal Year 2025 Therapeutic Solutions Division (TSD)

Consolidated Statement of Financial Position

Consolidated Cash Flows

Fiscal Year 2025 Consolidated Forecasts

Fiscal Year 2025 Forecasts by Business Segment

Q&A 1

Q&A 2

Q&A 3

Q&A 4

Q&A 5

Q&A 6

Q&A 7

Q&A 8

Back
Next

Download